Bridgefront Capital, LLC

Source: SEC Form 13F · as of Mar 2026

Bridgefront Capital, LLC holds 58 biotech & pharma companies tracked by BioSniper, totaling $36.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

58

Total value held

$36.2M

CompanySharesValue
AMGNAMGEN INC8,228$2.9M
GMOptec International, Inc.32,061$2.4M
RPRXRoyalty Pharma plc48,362$2.3M
ELANElanco Animal Health Inc76,917$1.8M
LLYELI LILLY & Co1,547$1.4M
ELVElevance Health Inc.4,632$1.4M
NVSNovartis AG7,404$1.1M
BIIBBIOGEN INC.6,010$1.1M
RYTMRHYTHM PHARMACEUTICALS, INC.12,495$1.1M
CGONCG Oncology, Inc.14,401$975K
UNHUnitedHealth Group Incorporated Common Stock (DE)3,309$895K
DVADaVita Inc.5,381$827K
BEAMBeam Therapeutics Inc.34,018$811K
WSTWest Pharmaceutical Services Inc.3,196$801K
ADMAADMA BIOLOGICS, INC.88,318$796K
RAREUltragenyx Pharmaceutical Inc.35,135$736K
RVMDREVOLUTION MEDICINES, INC.7,515$731K
SNDXSyndax Pharmaceuticals Inc31,101$727K
NVAXNOVAVAX INC86,918$708K
IMVTImmunovant, Inc.27,809$691K
BHVNBiohaven Ltd.81,378$688K
ADPTAdaptive Biotechnologies Corp45,115$626K
HLFHerbalife Ltd.39,649$584K
CPRXCATALYST PHARMACEUTICALS, INC.22,398$555K
ACHCAcadia Healthcare Company Inc.21,294$498K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)26,406$489K
SYRESpyre Therapeutics, Inc.8,652$436K
RGENREPLIGEN CORP3,409$402K
BCRXBIOCRYST PHARMACEUTICALS INC40,889$389K
XENEXenon Pharmaceuticals Inc.6,564$382K
EWTXEdgewise Therapeutics, Inc.11,809$372K
QGENQIAGEN N.V.9,268$371K
OCULOCULAR THERAPEUTIX, INC43,351$367K
INSPInspire Medical Systems Inc.6,773$349K
TEVATeva Pharmaceutical Industries Limited10,689$322K
UTHRUNITED THERAPEUTICS Corp534$317K
ROIVRoivant Sciences Ltd.11,209$310K
VERAVera Therapeutics, Inc.7,715$310K
TYRATyra Biosciences, Inc.7,911$303K
LQDALiquidia Corp7,345$277K
AXSMAxsome Therapeutics, Inc.1,624$274K
JANXJanux Therapeutics, Inc.19,692$274K
ZLABZai Lab Ltd14,529$273K
IDXXIDEXX LABORATORIES INC /DE476$267K
BBNXBeta Bionics Inc.25,909$260K
ALKSAlkermes plc.7,291$258K
NTLAIntellia Therapeutics, Inc.18,530$238K
ELVNEnliven Therapeutics, Inc.5,805$228K
TNGXTango Therapeutics, Inc.10,867$227K
AGIOAGIOS PHARMACEUTICALS, INC.6,551$222K
IDYAIDEAYA Biosciences, Inc.6,363$212K
IQVIQVIA Holdings Inc.1,225$209K
PHATPhathom Pharmaceuticals, Inc.14,954$166K
SDGRSchrodinger, Inc.12,831$146K
SPRYARS Pharmaceuticals, Inc.12,926$104K
NUSNu Skin Enterprises Inc.13,228$96K
VIRVir Biotechnology, Inc.10,427$93K
WVEWave Life Sciences Ltd.12,146$88K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Bridgefront Capital, LLC — Biotech 13F Holdings & Portfolio | BioSniper